<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher
  PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
<PublisherInfo>
<PublisherName>Springer-Verlag</PublisherName>
<PublisherLocation>Berlin/Heidelberg</PublisherLocation>
</PublisherInfo>
<Journal>
<JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
<JournalID>401</JournalID>
<JournalPrintISSN>0001-6322</JournalPrintISSN>
<JournalElectronicISSN>1432-0533</JournalElectronicISSN>
<JournalTitle>Acta Neuropathologica</JournalTitle>
<JournalAbbreviatedTitle>Acta Neuropathol</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Type="Primary">Medicine &amp; Public Health</JournalSubject>
        <JournalSubject Type="Secondary">Pathology</JournalSubject>
      </JournalSubjectGroup>
</JournalInfo>
<Volume>
<VolumeInfo VolumeType="Regular" TocLevels="0">
<VolumeIDStart>1</VolumeIDStart>
<VolumeIDEnd>1</VolumeIDEnd>
<VolumeIssueCount>5</VolumeIssueCount>
</VolumeInfo>
<Issue IssueType="Regular">
<IssueInfo TocLevels="0">
<IssueIDStart>2</IssueIDStart>
<IssueIDEnd>2</IssueIDEnd>
<IssueArticleCount>9</IssueArticleCount>
<IssueHistory>
<CoverDate>
  <DateString>1. August 1961</DateString>
  <Year>1961</Year>
  <Month>1</Month>
</CoverDate>

</IssueHistory>
<IssueCopyright>
<CopyrightHolderName>Springer-Verlag</CopyrightHolderName>
<CopyrightYear>1961</CopyrightYear>
</IssueCopyright>
</IssueInfo>
<Article ID="Art1">
<ArticleInfo Language="En" ArticleType="OriginalPaper" NumberingStyle="Unnumbered" TocLevels="0" ContainsESM="No">
<ArticleID>BF00685222</ArticleID>
<ArticleDOI>10.1007/BF00685222</ArticleDOI>
<ArticleSequenceNumber>1</ArticleSequenceNumber>
<ArticleTitle Language="En">Grey matter degeneration of the C.N.S. in carcinosis</ArticleTitle>
<ArticleCategory>Original Investigations</ArticleCategory>
<ArticleFirstPage>107</ArticleFirstPage>
<ArticleLastPage>112</ArticleLastPage>
<ArticleHistory>
<RegistrationDate>
<Year>2004</Year>
<Month>11</Month>
<Day>7</Day>
</RegistrationDate>
<Received>
<Year>1960</Year>
<Month>9</Month>
<Day>23</Day>
</Received>
</ArticleHistory>
<ArticleCopyright>
<CopyrightHolderName>Springer-Verlag</CopyrightHolderName>
<CopyrightYear>1961</CopyrightYear>
</ArticleCopyright><ArticleGrants Type="Regular"><MetadataGrant Grant="OpenAccess"/><AbstractGrant Grant="OpenAccess"/><BodyPDFGrant Grant="Restricted"/><BodyHTMLGrant Grant="Restricted"/><BibliographyGrant Grant="Restricted"/><ESMGrant Grant="Restricted"/></ArticleGrants>
<ArticleContext>
<JournalID>401</JournalID>
<VolumeIDStart>1</VolumeIDStart>
<VolumeIDEnd>1</VolumeIDEnd>
<IssueIDStart>2</IssueIDStart>
<IssueIDEnd>2</IssueIDEnd>
</ArticleContext>
</ArticleInfo>
<ArticleHeader>
<AuthorGroup>
<Author AffiliationIDS="Aff1">
<AuthorName DisplayOrder="Western">
<GivenName>W.</GivenName>
<GivenName>J.</GivenName>
<GivenName>C.</GivenName>
<FamilyName>Verhaart</FamilyName>
<Degrees>M. D.</Degrees>
</AuthorName>
</Author>
<Affiliation ID="Aff1">
<OrgDivision>Institute of Neurological Sciences</OrgDivision>
<OrgName>State University Leyden</OrgName>
<OrgAddress>
<Country>the Netherlands</Country>
</OrgAddress>
</Affiliation>
</AuthorGroup>
<Abstract ID="Abs1" Language="En">
<Heading>Summary</Heading>
<Para>Two cases of grey matter degeneration of the C. N. S. due to carcinosis are described.</Para>
<Para>In the first besides elements of the cerebellum other grey complexes also were affected, in the second manifestations of deficiency-encephalopathy were found. It was emphasized that systematic diseases mostly are not so systematic as generally accepted, that many grey matter degenerations are not systematic at all, and that the carcinogenous affections do not differ essentially from the latter.</Para>
<Para>C. N. S. affections in carcinosis are to be considered as unspecific, unsystematic, as only one of many etiologically different ganglion cell degenerations in which the cerebellar cortex relatively frequently partakes, as unpredictable with respect to both their occurrence at all and to the distribution and the intensity of the degeneration.</Para>
</Abstract>
<Abstract ID="Abs2" Language="De">
<Heading>Zusammenfassung</Heading>
<Para>Zwei Fälle von Degeneration der grauen Substanz des Zentralnervensystems bei Carcinose werden beschrieben. Im ersten Falle sind außer den Elementen des Kleinhirns auch andere graue Gebiete betroffen, im zweiten Fall finden sich Zeichen von Mangel-Encephalopathie. Es wird betont, daß System-Krankheiten meistens nicht so systematisch, wie allgemein angenommen, sind, daß viele Degenerationen der grauen Substanz überhaupt nicht systematisch sind und daß die carcinogenen Affektionen sich von den letzteren nicht wesentlich unterscheiden.</Para>
<Para>Die Affektion des zentralen Nervensystems bei Carcinose muß man als unspezifisch und unsystematisch betrachten, als eine der ätiologisch verschiedenen Formen von Ganglienzell-Degenerationen, bei denen die Kleinhirnrinde relativ häufig beteiligt ist, sowie als nicht vorausbestimmbar sowohl hinsichtlich ihres Auftretens überhaupt als hinsichtlich der Verteilung und der Stärke der Degeneration.</Para>
</Abstract>
<ArticleNote Type="Misc">
<SimplePara>With 2 Figures in the Text</SimplePara>
</ArticleNote>
</ArticleHeader>
<BodyRef FileRef="BodyRef/PDF/401_2004_Article_BF00685222.pdf" TargetType="PDF"/>
</Article>
</Issue>
</Volume>
</Journal>
</Publisher>